What is the price target for MELE stock?
20 analysts have analysed MELE.BR and the average price target is 63.91 EUR. This implies a price decrease of -6.91% is expected in the next year compared to the current price of 68.65.
EBR:MELE • BE0165385973
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MELEXIS NV (MELE.BR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 964.298M 15.32% | 932.808M -3.27% | 839.617M -9.99% | 867.17M 3.28% | 945.74M 9.06% | 1.026B 8.49% | 1.149B 11.99% | 1.189B 3.48% | 1.244B 4.63% | 1.388B 11.58% | 1.506B 8.50% | |
| EBITDA YoY % growth | 313.755M 13.30% | 274.498M -12.51% | 187.302M -31.77% | 205.58M 9.76% | 245.93M 19.63% | 281.33M 14.39% | 351.38M 24.90% | 329.99M -6.09% | 285.76M -13.40% | 444.07M 55.40% | 520.13M 17.13% | |
| EBIT YoY % growth | 268.586M 15.90% | 226.757M -15.57% | 133.963M -40.92% | 155.77M 16.28% | 193.72M 24.36% | 224.15M 15.71% | 272.21M 21.44% | 276.76M 1.67% | 295.24M 6.68% | 344.54M 16.70% | 373.66M 8.45% | |
| Operating Margin | 27.85% | 24.31% | 15.96% | 17.96% | 20.48% | 21.85% | 23.69% | 23.28% | 23.73% | 24.82% | 24.81% | |
| EPS YoY % growth | 5.18 6.15% | 4.23 -18.34% | 2.79 -34.04% | 3.01 8.00% | 3.83 27.10% | 4.51 17.66% | 5.83 29.49% | 5.38 -7.84% | 4.52 -15.89% | 7.51 66.14% | 8.87 18.06% |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.67 9.52% | 0.83 -11.75% | 1.00 46.77% | 0.97 73.28% | 0.91 36.18% | 1.03 24.07% | 1.14 14.15% | 1.06 9.01% |
| Revenue Q2Q % growth | 206.74M 4.28% | 222.91M 5.35% | 237.28M 10.22% | 240.61M 12.18% | 225.85M 9.24% | 240.53M 7.90% | 250.15M 5.42% | 253.1M 5.19% |
| EBITDA Q2Q % growth | 47.169M 14.33% | 53.244M -14.62% | 60.131M -23.01% | 60.51M -28.66% | 56.387M 19.54% | 62.967M 18.26% | 68.955M 14.67% | 64.763M 7.03% |
| EBIT Q2Q % growth | 34.618M 19.44% | 41.12M 15.34% | 47.95M 26.70% | 48.136M 52.89% | 45.321M 30.92% | 51.182M 24.47% | 56.698M 18.24% | 52.362M 8.78% |
All data in EUR
20 analysts have analysed MELE.BR and the average price target is 63.91 EUR. This implies a price decrease of -6.91% is expected in the next year compared to the current price of 68.65.
MELEXIS NV (MELE.BR) will report earnings on 2026-04-29.
The consensus EPS estimate for the next earnings of MELEXIS NV (MELE.BR) is 0.67 EUR and the consensus revenue estimate is 206.74M EUR.
The consensus rating for MELEXIS NV (MELE.BR) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.